ALLARITY THERAPEUTICS INC (ALLR) Stock Earnings & Estimates
NASDAQ:ALLR - US0167445008 - Common Stock
1.43 USD
+0.49 (+51.92%)
1.35 USD
-0.08 (-5.59%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 120K | N/A -100.00% | N/A | 8.758M | ||||||
| EBITDA YoY % growth | -10.066M | N/A 17.81% | N/A -219.71% | N/A 36.36% | N/A -1.54% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -10.117M | N/A 17.77% | N/A -219.22% | -32.165M 36.39% | -17.045M -1.40% | -24.085M -40.61% | 12.889M 153.51% | 13.056M 1.30% | -16.64M -227.45% | |
| Operating Margin | -8,430.83% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -190.00% | |
| EPS YoY % growth | N/A | N/A | N/A | -1,860,969.60 | -125,967.96 93.35% | -79.68 99.94% | -0.90 98.87% | -0.85 5.68% | -25.70 -2,936.14% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.21 97.22% | -0.21 97.44% | -0.21 | -0.21 -42.80% | -0.21 | -0.21 |
| Revenue Q2Q % growth | ||||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 3.264M 225.06% | 3.264M 144.61% | 3.264M 207.51% | 3.264M 178.97% | 3.264M | 3.264M |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.15 95.45% | -0.21 | 0.06 | 29.97% |
| Q4 2024 Q2Q % growth | 96.76% | -8.35 | % | |
| Q3 2024 Q2Q % growth | -7.71 99.43% | -8.69 | 0.98 | 11.28% |
| Q2 2024 Q2Q % growth | -3.30 99.98% | -8.78 | 5.48 | 62.42% |
| Q1 2024 Q2Q % growth | -664.20 99.38% | -53.86 | -610.34 | -1,133.29% |
| Q4 2023 Q2Q % growth | -258.00 99.87% | -153.00 | -105.00 | -68.63% |
| Q3 2023 Q2Q % growth | -1,344.00 99.76% | -5,000.04 | 3,656.04 | 73.12% |
| Q2 2023 Q2Q % growth | -15,768.00 96.39% | -6,848.28 | -8,919.72 | -130.25% |
| Q1 2023 Q2Q % growth | -106,320.00 | -192,877.92 | 86,557.92 | 44.88% |
| Q4 2022 Q2Q % growth | -193,200.00 | -357,285.60 | 164,085.60 | 45.93% |
| Q3 2022 Q2Q % growth | -571,200.00 | -218,484.00 | -352,716.00 | -161.44% |
| Q2 2022 Q2Q % growth | -436,800.00 | -359,856.00 | -76,944.00 | -21.38% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |